P3502A novel interactome to guide therapy and avoid heart failure in cardiac cancer patients

Styliani Geronikolou; Athanasia Pavlopoulou; George Chrousos; Dennis V. Cokkinos

doi:10.1093/eurheartj/ehy563.p3502

Discussion(0)

No comments yet. Be the first to comment.

Related publications

Chapter in a book2014

The current status of cardiac resynchronisation therapy for heart failure

Rajiv Sankaranarayanan, Clifford J. Garratt

Article2025

Clinical Phenotypes in Relation to Outcomes in Heart Failure Patients With Cardiac Resynchronization Therapy and Defibrillators (CRT‐D): An Unsupervised Cluster Analysis

Luigi Gerra, Tommaso Bucci, Arnaud Bisson, Alexandre Bodin, Bertrand Pierre, Giuseppe Boriani, Professor Gregory Lip, Laurent Fauchier

Article2014

Abstract 17498: Prognostic Importance of Novel Cardiac and Renal Biomarkers in Patients With Heart Failure, Reduced Ejection Fraction and Anemia

Paul Welsh, Changhong Yu, John J.V. McMurray, Inder S. Anand, Naveed Sattar, Dirk J. van Veldhuisen, Lars Gullestad, Aldo Maggioni, Akshay S. Desai, Scott D. Solomon, Sunfa Cheng, Marc A. Pfeffer, Lei Kou, Karl Swedberg, James B. Young

Article2008

11.8 Addition of Canrenone to Optimal Therapy Improves Cardiac Geometry and Function in Patients with Systolic Heart Failure and Metabolic Syndrome: the AREA-IN-CHF Study

Marcello Chinali, Giovanni de Simone, Gian Francesco Mureddu, Ilaria Botta, Giuseppe Cacciatore, Maurizio Porcu, Aldo Maggioni, Alessandro Boccanelli

Article2024

Cardiac rehabilitation and adverse events among adult patients with simple congenital heart disease and heart failure

Benjamin J. R. Buckley, Thijs P. Kerstens, Madeleine France‐Ratcliffe, Professor Gregory Lip, Dick H. J. Thijssen